DaVita to Treat Kidney Patients in Saudi Arabia
DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it has signed a major tender from the Kingdom of Saudi Arabia’s Ministry of Health to treat half of the approximately 10,000 dialysis patients currently under the Ministry’s care.
Under the award, DaVita will operate as many as 80 centers and is undertaking a substantial recruitment effort to attract new clinical and administrative teammates from within Saudi Arabia and across the world.
“This is another important step in our vision for expanding our kidney care services internationally,” said Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners Inc. “It is an honor for DaVita to work with the Ministry of Health to deliver high-quality kidney care to its patients.”
[ Also Visit: RMN Stars – Your Gateway to the Entertainment World ]
As in many parts of the world, prevalence of chronic kidney disease in Saudi Arabia has accelerated over the past three decades due largely to changing lifestyles, population growth, urbanization and longer life expectancies.
DaVita will also be a prime resource to the Ministry of Health in identifying ways to prevent kidney disease within the Kingdom of Saudi Arabia.
For more information on DaVita’s efforts in Saudi Arabia, visit DaVita.com/SA.
In the picture above: Left to right: Vice Minister of Health and Health Affairs, Dr. Mansour Naser Al-Howasi, Charge d’Affaires, U.S. Embassy in Riyadh, Tim Lenderking, Minister of Health, Dr. Abdullah bin Abdul Aziz Al Rabeeah, Chief Operating Officer of DaVita.
